Menu
Back to User profile » Dr Tamas Treuer
Papers published by Dr Tamas Treuer:
Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder
Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM
Patient Preference and Adherence 2017, 11:1019-1025
Published Date: 6 June 2017
Sex differences in the course of schizophrenia across diverse regions of the world
Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM
Neuropsychiatric Disease and Treatment 2016, 12:2927-2939
Published Date: 14 November 2016
Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine
Montgomery W, Kadziola Z, Ye W, Xue HB, Liu L, Treuer T
Neuropsychiatric Disease and Treatment 2015, 11:177-183
Published Date: 19 January 2015
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
Xue HBH, Liu L, Zhang H, Montgomery W, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:841-864
Published Date: 16 May 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
Ye W, Montgomery W, Kadziola Z, Liu L, Xue H, Stensland MD, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:869-878
Published Date: 16 May 2014
Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
Zhao J, Ou J, Xue H, Liu L, Montgomery W, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:355-359
Published Date: 19 February 2014
Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia
Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM
Patient Preference and Adherence 2013, 7:987-995
Published Date: 30 September 2013
The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy
Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H
ClinicoEconomics and Outcomes Research 2013, 5:407-418
Published Date: 14 August 2013